Semnur Pharmaceuticals, Inc. (SMNR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2023: -$3.17M2024: -$4.69M2025: -$160.42M-$160.42M
2023Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$160.42M-3320.4%
2024-$4.69M-47.8%
2023-$3.17M